)
)
MacroGenics Investor Relations Material
Latest events
Q3 2024
MacroGenics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from MacroGenics Inc
Access all reports
MacroGenics Inc. is a biopharmaceutical company focused on developing and commercializing antibody-based therapies for the treatment of cancer and other serious diseases. The company's pipeline includes immuno-oncology therapies designed to harness the immune system to target and destroy cancer cells. MacroGenics employs its proprietary antibody platforms to create innovative treatments that address unmet medical needs in oncology and other therapeutic areas. The company is headquartered in Rockville, Maryland, and its shares are listed on the NASDAQ.
Key slides for MacroGenics Inc
Study Update
MacroGenics Inc
Study Update
MacroGenics Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
MGNX
Country
🇺🇸 United States